Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 398

1.

Assessment and Management of Patients With Metastatic Spinal Cord Compression: A Multidisciplinary Review.

Lawton AJ, Lee KA, Cheville AL, Ferrone ML, Rades D, Balboni TA, Abrahm JL.

J Clin Oncol. 2018 Nov 5:JCO2018781211. doi: 10.1200/JCO.2018.78.1211. [Epub ahead of print]

PMID:
30395488
2.

Potential Prognostic Factors of Downstaging Following Preoperative Chemoradiation for High Rectal Cancer.

Treder M, Vogelsang RP, Janssen S, Schild SE, Holländer NH, Rades D.

In Vivo. 2018 Nov-Dec;32(6):1481-1484. doi: 10.21873/invivo.11403.

PMID:
30348705
3.

Macrophage Migration Inhibitory Factor (MIF) Drives Murine Psoriasiform Dermatitis.

Bezdek S, Leng L, Busch H, Mousavi S, Rades D, Dahlke M, Zillikens D, Bucala R, Sadik CD.

Front Immunol. 2018 Oct 2;9:2262. doi: 10.3389/fimmu.2018.02262. eCollection 2018.

4.

Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphoma.

Witte HM, Riecke A, Mayer T, Bartscht T, Rades D, Lehnert H, Merz H, Fetscher S, Biersack H, Gebauer N.

J Cancer Res Clin Oncol. 2018 Oct 16. doi: 10.1007/s00432-018-2772-8. [Epub ahead of print]

PMID:
30327940
5.

Role of Neoadjuvant Radio-chemotherapy for the Treatment of High Rectal Cancer.

Treder M, Janssen S, Holländer NH, Schild SE, Rades D.

Anticancer Res. 2018 Sep;38(9):5371-5377. doi: 10.21873/anticanres.12866.

PMID:
30194191
6.

Proteome Profiling of Primary Pancreatic Ductal Adenocarcinomas Undergoing Additive Chemoradiation Link ALDH1A1 to Early Local Recurrence and Chemoradiation Resistance.

Oria VO, Bronsert P, Thomsen AR, Föll MC, Zamboglou C, Hannibal L, Behringer S, Biniossek ML, Schreiber C, Grosu AL, Bolm L, Rades D, Keck T, Werner M, Wellner UF, Schilling O.

Transl Oncol. 2018 Dec;11(6):1307-1322. doi: 10.1016/j.tranon.2018.08.001. Epub 2018 Aug 30.

7.

Preliminary Results from a Prospective Study Comparing White Blood Cell and Neutrophil Counts from a Laboratory to Those Measured with a New Device in Patients with Breast Cancer.

Lohman AC, VAN Rijn I, Lindhardt CL, Vonthein R, Rades D, Holländer NH.

In Vivo. 2018 Sep-Oct;32(5):1283-1288. doi: 10.21873/invivo.11378.

8.

Predicting the Ambulatory Status of Patients Irradiated for Metastatic Spinal Cord Compression (MSCC) from Head-and-neck Cancer.

Rades D, Staackmann C, Janssen S.

Anticancer Res. 2018 Aug;38(8):4833-4837. doi: 10.21873/anticanres.12794.

PMID:
30061256
9.

A Tool to Predict the Probability of Intracerebral Recurrence or New Cerebral Metastases After Whole-brain Irradiation in Patients with Head-and-Neck Cancer.

Staackmann C, Janssen S, Schild SE, Rades D.

Anticancer Res. 2018 Jul;38(7):4199-4202. doi: 10.21873/anticanres.12714.

PMID:
29970550
10.

Inhibition of GSK3α/β impairs the progression of HNSCC.

Schulz L, Pries R, Lanka AS, Drenckhan M, Rades D, Wollenberg B.

Oncotarget. 2018 Jun 12;9(45):27630-27644. doi: 10.18632/oncotarget.25250. eCollection 2018 Jun 12.

11.

A Specific Survival Score for Patients Receiving Local Therapy for Single Brain Metastasis from a Gynecological Malignancy.

Rades D, Dziggel L, Schild SE.

In Vivo. 2018 Jul-Aug;32(4):825-828. doi: 10.21873/invivo.11314.

12.

Clinical Results of Mean GTV Dose Optimized Robotic-Guided Stereotactic Body Radiation Therapy for Lung Tumors.

Baumann R, Chan MKH, Pyschny F, Stera S, Malzkuhn B, Wurster S, Huttenlocher S, Szücs M, Imhoff D, Keller C, Balermpas P, Rades D, Rödel C, Dunst J, Hildebrandt G, Blanck O.

Front Oncol. 2018 May 17;8:171. doi: 10.3389/fonc.2018.00171. eCollection 2018.

13.

An Instrument for Estimating the 6-Month Survival Probability After Whole-brain Irradiation Alone for Cerebral Metastases from Gynecological Cancer.

Janssen S, Hansen HC, Schild SE, Rades D.

Anticancer Res. 2018 Jun;38(6):3753-3756. doi: 10.21873/anticanres.12656.

PMID:
29848738
14.

Hyperfractionated or Accelerated Hyperfractionated Re-irradiation with ≥42 Gy in Combination with Paclitaxel for Secondary/Recurrent Head-and-Neck Cancer.

Rades D, Bartscht T, Idel C, Schild SE, Hakim SG.

Anticancer Res. 2018 Jun;38(6):3653-3656. doi: 10.21873/anticanres.12641.

PMID:
29848723
15.

Multimodal Anti-tumor Approaches Combined with Immunotherapy to Overcome Tumor Resistance in Esophageal and Gastric Cancer.

Bolm L, Käsmann L, Paysen A, Karapetis C, Rades D, Wellner UF, Keck T, Watson DI, Hummel R, Hussey DJ.

Anticancer Res. 2018 Jun;38(6):3231-3242. doi: 10.21873/anticanres.12588. Review.

PMID:
29848670
16.

Treatment planning for spinal radiosurgery : A competitive multiplatform benchmark challenge.

Moustakis C, Chan MKH, Kim J, Nilsson J, Bergman A, Bichay TJ, Palazon Cano I, Cilla S, Deodato F, Doro R, Dunst J, Eich HT, Fau P, Fong M, Haverkamp U, Heinze S, Hildebrandt G, Imhoff D, de Klerck E, Köhn J, Lambrecht U, Loutfi-Krauss B, Ebrahimi F, Masi L, Mayville AH, Mestrovic A, Milder M, Morganti AG, Rades D, Ramm U, Rödel C, Siebert FA, den Toom W, Wang L, Wurster S, Schweikard A, Soltys SG, Ryu S, Blanck O.

Strahlenther Onkol. 2018 Sep;194(9):843-854. doi: 10.1007/s00066-018-1314-2. Epub 2018 May 25.

PMID:
29802435
17.

Analysis of predictors of pain response in patients with bone metastasis undergoing palliative radiotherapy: Does age matter?

Cacicedo J, Gómez-Iturriaga A, Navarro A, Morillo V, Willisch P, Lopez-Guerra JL, Illescas A, Casquero F, Del Hoyo O, Ciervide R, Martinez-Indart L, Bilbao P, Rades D.

J Med Imaging Radiat Oncol. 2018 May 23. doi: 10.1111/1754-9485.12749. [Epub ahead of print]

PMID:
29797486
18.

Local recurrence of breast cancer: conventionally fractionated partial external beam re-irradiation with curative intention.

Janssen S, Rades D, Meyer A, Fahlbusch FB, Wildfang I, Meier A, Schild S, Christiansen H, Henkenberens C.

Strahlenther Onkol. 2018 Sep;194(9):806-814. doi: 10.1007/s00066-018-1315-1. Epub 2018 May 23.

PMID:
29796694
19.

The Glasgow prognostic score at diagnosis is an independent predictor of survival in advanced stage classical Hodgkin lymphoma.

Witte H, Biersack H, Kopelke S, Rades D, Merz H, Bernard V, Lehnert H, Fetscher S, Gebauer N.

Br J Haematol. 2018 May 22. doi: 10.1111/bjh.15198. [Epub ahead of print] No abstract available.

PMID:
29785776
20.

Subfoveal Choroidal Thickness as a Potential Predictor of Clinical Response to Stereotactic Radiotherapy for Neovascular Age-Related Macular Degeneration.

Ranjbar M, Kurz M, Holzhey A, Rades D, Grisanti S.

Ophthalmic Surg Lasers Imaging Retina. 2018 May 1;49(5):320-328. doi: 10.3928/23258160-20180501-05.

PMID:
29772042

Supplemental Content

Loading ...
Support Center